No Finish Line Means No Limits
We are focused on constant innovation to improve patients’ lives and arming healthcare providers with
life-changing solutions in gastroenterology.
Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to
the prevention and treatment of gastrointestinal (GI) diseases and disorders. We are focused on
constantly innovating to improve patients’ lives.
We gain a deeper understanding of the GI conditions our products treat by connecting with the patients
who use them and the healthcare professionals (HCPs) who prescribe them. Our therapeutic areas of
expertise include overt hepatic encephalopathy, irritable bowel
syndrome with diarrhea, irritable bowel syndrome with constipation, chronic idiopathic constipation,
opioid-induced constipation, bowel preparation and ulcerative colitis.
We employ dedicated and innovative team members who are driven to problem-solve. We strive to improve
upon existing treatments, uncover new breakthroughs, and deliver comprehensive practice support to arm
HCPs with life-changing solutions.
The landscape of healthcare will continue to change, and new patients will continue to present with new
needs. That’s why there is no finish line for our innovation and no limit to our potential.